4//SEC Filing
Lebwohl David 4
Accession 0001209191-22-015960
CIK 0001652130other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:00 PM ET
Size
13.6 KB
Accession
0001209191-22-015960
Insider Transaction Report
Form 4
Lebwohl David
EVP, Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-01-01+3,187→ 11,973 total - Award
Common Stock
2022-03-01+13,816→ 24,738 total - Award
Stock Option (right to buy)
2022-03-01+13,816→ 13,816 totalExercise: $79.85Exp: 2032-02-28→ Common Stock (13,816 underlying) - Sale
Common Stock
2022-01-01$112.24/sh−1,051$117,964→ 10,922 total - Exercise/Conversion
Restricted Stock Unit
2022-01-01−3,187→ 9,563 totalFrom: 2022-01-01Exp: 2031-03-02→ Common Stock (3,187 underlying)
Footnotes (6)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]Includes 72 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on December 31, 2021.
- [F3]Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on January 1, 2022.
- [F4]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F5]On March 3, 2021, the reporting person was granted 12,750 RSUs pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Company's common stock upon vesting, with 25% of the RSU vesting on January 1, 2022 and the remaining awards vesting as to 25% in substantially equal annual installments thereafter.
- [F6]This option was granted on March 1, 2022 with respect to shares of Common Stock, with 33% vesting on January 1, 2023 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001810882
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:00 PM ET
- Size
- 13.6 KB